24PCT ,662 4, , % 22.5% 3.3%72.1% 26.9% 1.0% 66.40% 33.57% 0.03% 67.2% 12.8% 12.5% 7.5% 65.8% 14.2% 11.6% 8.4%

Size: px

Start display at page:

Download "24PCT ,662 4, , % 22.5% 3.3%72.1% 26.9% 1.0% 66.40% 33.57% 0.03% 67.2% 12.8% 12.5% 7.5% 65.8% 14.2% 11.6% 8.4%"

谓征烽叶
7 years ago
Views:

1 BioMedGPS 19% HeartR Cera CeraFlex AegisyAnkura Green Arrow/Blue Arrow/Red Arrow Cera CeraFlex Supporter PerMed FuStar 261,450 HeartR Cera PCT CeraFlex CE FDA 10 (PFO)(LAA)(DEB) PFO

2 24PCT ,662 4, , % 22.5% 3.3%72.1% 26.9% 1.0% 66.40% 33.57% 0.03% 67.2% 12.8% 12.5% 7.5% 65.8% 14.2% 11.6% 8.4% 68.4% 13.1% 6.9% 11.6% % % BioMedGPS 19% HeartR Cera CeraFlex

3 (ASD) (PDA)(VSD) ASD PDA VSD HeartR Cera CeraFlex Cera Cera Cera ASD VSD PDA 97.4% 97.4% 98.7% PCT HeartR Cera CeraFlex BioMedGPS55% 19% Aegisy (VCF) Ankura TAA AAA Green Arrow/Blue Arrow/Red Arrow PBAV PBMV PBPV Cera/CeraFlex Supporter FuStar

4 Aegisy VCF VCFAnkura TAA AAA CE (FDA) 10 PFO LAA(PTCA) (PTA) (Sankt Katharinen Hospital)) PFO

5 24PCT 11.8% 14.7% 11.1% ,450 61

6 4,100 1,900 ISO ISO YY/T CE FDA Johnson & Johnson Cordis Cordis China 30

7 10 MicroPort PTCA Cera AegisyAnkura CE

8 10 PFO LAA PTCA PTA BioMedGPS PFO 10 PFO CE PFO BioMedGPS LAA 50 LAA PFO LAA 19 CE Cera/CeraFlex Aegisy PFO CE CE 30 FuStar FDA

9 Cera 19 CE 2 FDA 14

10 (6) (7) HeartR (2) ASD VSD (1) 3,846-13,172 (CHD) PDA CHD (3) Cera CE (4) CeraFlex CE Blue Arrow (2) PBMV 3,675-4,051 CE Red Arrow PBPV CE Green Arrow PBAV CE SteerEase CE

11 (6) (7) SeQure FDA 993 CE Aegisy 3,846-4,304 CE Ankura TAA AAA 18,803-20,857 Cera CE 1,950-3,846 CeraFlex CE FuStar FDA 1655 CE PerMed (7) (1) HeartR VSD PDA CHD (2) (3) HeartR PDA ASD HeartR VSD (4) Cera ASD (5) CEFDA CE CE (6) (7) PerMed

12 HeartR Cera CeraFlex ASD VSD PDA Blue Arrow PBMV Red Arrow PBPV Green Arrow PBAV Aegisy Ankura TAA AAA PerMed

13 (i) (ii) CE(iii) (iv) 15

14 CHD (PFO) PFO (PCTA) (PTA) (DEB) PCTA PTA CHD LAA (LAA) (BV)

15 CHD CHD CHD CHD 15 CHD 81.2% 84.8% 84.5% CHD BioMedGPS(CHD) 19%CHD CHD 59.1% 58.3% 51.4%

16 HeartR HeartR PDA ASD VSD Cera CeraFlex Cera CeraFlex Cera CeraFlex CE HeartR Cera CeraFlex PET eptfe PET eptfe HeartR Cera CeraFlex ASD (ASD)ASD PET 26ASD ASD30.3% 30.8% 25.6%

17 PDA(PDA)PDA eptfe 10PDA PDA18.7% 17.4% 15.5% VSD (VSD)VSD eptfe 52VSD VSD10.1% 10.1% 10.3% PFO PFO PFO PFO PFO PFO BioMedGPS 20% PFO PFO 10 LAA LAA LAA LAA LAABioMedGPS LAA50 PFO LAA CHD (PBAV) (PBMV)(PBPV) PBAV PBMV PBPV CEPBMV PBAV PBPVPBMV 1.4% 1.6% 3.0%

18 PTCA PTA PTCA PTA Aegisy CE (VCF) Y 15.3% 16.8% 21.1% 15 eptfe (TAA)(AAA) Y CE 6.8% 9.7% 12.0% PTFE Cera CeraFlex Cera CeraFlex

19 Cera CeraFlex CeraFlex Cera CeraFlex CE 0.1% 0.3% 0.3%

20 SteerEase CE FuStar CE FuStar FDA FuStar 16.2% 11.9% 10.5% 11.8% 14.7% 11.1% % 9.0% 11.2% PFO 24 PCT 71 30

24 (Sankt Katharinen Hospital) 11 4 Cera CeraFlex Cera VSD PFO

25 11Cera ASD VSD PDA Cera ASD VSD PDA Cera, Cera HeartR Cera Cera Cera Cera

26 本網上預覽資料集為草擬本當中所載信息並不完整並可予更改本網上預覽資料集必須與其封面所載之警告一節一併閱讀業務月我們向中國分銷商銷售的金額分別佔收益約57.8% 62.1%及65.9% 而向國際分銷商銷售的金額分別佔收益約32.8% 34.3%及31.5% 於二零零九年及二零一零年以及截至二零一一年四月三十日止四個月向五大分銷商銷售的金額分別佔收益約 37.2% 28.5%及 28.2% 於二零零九年及二零一零年以及截至二零一一年四月三十日止四個月向中國最大分銷商銷售的金額分別佔收益約11.6% 8.1%及7.2% 於二零零九年及二零一零年以及截至二零一一年四月三十日止四個月向國際最大分銷商銷售的金額分別佔收益約7.6% 7.7%及 4.4% 於二零零九年及二零一零年及二零一一年首四個月佔收益10%以上的分銷商分別為兩名零及零就董事所知概無擁有本集團已發行股本超過5%的任何董事或其聯繫人及現有股東於本集團的任何一家經銷商中擁有任何權益隨著我們擴張國際銷售網絡加大力度進行市場推廣且產品在國際市場的知名度不斷提高我們預期國際銷售額佔總銷售額的百分比在近期將大幅增長我們擁有龐大的產品分銷網絡由全球157名分銷商組成包括中國109名印度18 名歐洲包括俄羅斯 14名及其他地區16名共覆蓋逾1,450家醫院下圖顯示我們覆蓋全球的分銷商的位置 146

27 % 65.8% 68.4% CE

28 60 60

29 % 9030% FOB (A)A-i A-ii A-iii (B) (C) *

30 (B) (C) (A-i) (B) (A-ii) (A-iii) (C) % 11.2% 7.2% 10.9% 7.8% 4.4% 1.4% 4.6% 0.7% 0.5% 0.2% 0.5% 2.8% 3.2% 2.3%

31 (i) (ii)(iii) 60 (i) 75% (ii) (iii)(iv) (v) (vi) (i) 30 (ii) (iii)

32 Zhan Guowei Mark Cibuzar Zhan Guowei 11 Johnson & Johnson Mark Cibuzar Occlutech AGA (i) (ii) (iii)

33 (i) (ii) (iii) HeartR ASD VSD

34 2.4% 14.3% 21.3% 5.0% (1) (1) 16

35 20

36 2,300 1,800 1,900

37 22,366 28,591 8,008 17,678 14,892 5,184 (%) % 7,854 7,854 3,040 3,548 4,354 2,611 (%) % 1,584 1, , (%) % (1) Cera Cera (2) (3) GMP 6,417

38 48 7 (i) (ii) (iii) (iv)

39 31 CE GMP GMP GMP GMP GMP GMP FDA CE ISO13485:2003 (iii)

40 (i) (ii) (iii) (iv) PET eptfe 36.5% 58.2% 52.3% % 35.4% 27.9% 14.1% 11.3% 12.9% Lifetech of America CorporationLifetech of America Corporation Lifetech of America CorporationLifetech of America CorporationLifetech LifetechLifetech

41 of America CorporationLifetech Lifetech of America Corporation(i)(ii) (iii) Lifetech of America Corporation Lifetech Lifetech Lifetech of America Corporation Lifetech of America Corporation [ ] Lifetech of America Corporation Lifetech of America Corporation 5% FustarTM CeraFlex HeartR Cera

42 (i) (ii) (iii) PFO 24 PCT % 40.3% 39.4%

43 15 PCTPCT PCT PCT PCT PCT PCT 30 PCT Lifetech 4

45 AGA/St. Jude s Medical W.L. Gore & Associates Occlutech GmbH Johnson & Johnson Medtronic Cook Medical W.L. Gore & Associates B. Braun Medical Lepu Medical TechnologyShanghai Memory Alloy Co., Ltd. Starway Medical MicroPort Medical HeartR Cera HeartR

47 500 AAA

48 ,100

49 1,800 1,900 1,

50 3,000 9,400 AGA AGA AGA AGA AGA A A AGA

51 A AGA AGA B B B AGA B AGA AGA (i) CC (ii) AGAC(iii) AGA (i) C (ii) (iii) AGA AGA 2,100, , AGA AGA AGAC (i) C PCT(ii) C (iii) C AGA AGAAGA 20,000

52 AGA 55,000 AGA AGA Saikrishna & Associates AGA AGA Saikrishna & Associates HeartR AGAC AGA AGA (i) AGA (ii)aga HeartR HeartR % 93.6% 92.7% 36.8% 38.9% 38.4% 12.1% 13.3% 12.1% 12.8% 14.2% 13.1% 14.2% 14.7% 13.0% HeartR ASD VSD HeartR ASD VSD 15.2% 13.2% 5.6% HeartR ASD VSD AGA HeartR ASD VSDHeartR ASD VSD

53 AGAC HeartRAGA CAGA C C AGA AGA AGA (i)agac PCT (ii)aga C AGA HeartR ASD VSD HeartR ASD VSDHeartR ASD VSD HeartR HeartR HeartR ASD ASD ASD VSD VSD VSD HeartR ASD 4,413, ,497, , HeartR VSD 97, , ,510, ,828, , HeartR ASD VSDHeartR ASD VSD 15.2% 13.2% 5.6% 5.7% 4.6% 1.6%

54 C HeartR ASD VSD HeartR ASD VSD HeartR ASD VSD 5% AGA (i)(ii) (iii) 6,300 (iv)18,

,400, ,400, %2.0% ,200, / / , / /

,400, ,400, %2.0% ,200, / / , / / 2011 5 31 1514,336 200820092010 201010-11 10-11 2010 200820092010 6 302010 12 31 720,000780,000760,000250,000 309,400,000 360,400,000 353,200,000 123,700,000 19 15 33435 514 2010 IELTS TOEFL 2010 12 60%